Quartz
US · 14 mins ago
AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb
A combination of the two pharmaceutical companies could create an entity valued at nearly $400 billion, according to the Financial Times
Do you trust Quartz?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!